COc1ccc(C2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?